{\reset@font\mtcSfont\mtc@string\contentsline{section}{\noexpand \leavevmode \numberline {1.1}MLL-AF9\xspace and MLL-rearranged leukemia}{\reset@font\mtcSfont 9}{section.1.1}}
{\reset@font\mtcSfont\mtc@string\contentsline{section}{\noexpand \leavevmode \numberline {1.2}DNA methylation in acute myeloid leukemia}{\reset@font\mtcSfont 10}{section.1.2}}
{\reset@font\mtcSfont\mtc@string\contentsline{section}{\noexpand \leavevmode \numberline {1.3}Enhancers}{\reset@font\mtcSfont 11}{section.1.3}}
{\reset@font\mtcSSfont\mtc@string\contentsline{subsection}{\noexpand \leavevmode \numberline {1.3.1}Enhancers in general}{\reset@font\mtcSSfont 11}{subsection.1.3.1}}
{\reset@font\mtcSSfont\mtc@string\contentsline{subsection}{\noexpand \leavevmode \numberline {1.3.2}Enhancers contribute to leukemogenesis}{\reset@font\mtcSSfont 12}{subsection.1.3.2}}
{\reset@font\mtcSfont\mtc@string\contentsline{section}{\noexpand \leavevmode \numberline {1.4}Previous findings}{\reset@font\mtcSfont 13}{section.1.4}}
{\reset@font\mtcSfont\mtc@string\contentsline{section}{\noexpand \leavevmode \numberline {1.5}Aim of this thesis}{\reset@font\mtcSfont 14}{section.1.5}}
